APA (7th ed.) Citation

N, F., YB, D., T, A., R, L., N, S., T, L., . . . S, R. (2024). In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab. Annals of hematology, 103(12), 5861. https://doi.org/10.1007/s00277-024-06130-y

Chicago Style (17th ed.) Citation

N, Fadaos, et al. "In Patients with Follicular Lymphoma, Delayed-onset Neutropenia Induced by Anti-CD20 Monoclonal Antibodies Frequently Occurs During Maintenance Therapy and Is Preferentially Associated with Obinutuzumab." Annals of Hematology 103, no. 12 (2024): 5861. https://doi.org/10.1007/s00277-024-06130-y.

MLA (9th ed.) Citation

N, Fadaos, et al. "In Patients with Follicular Lymphoma, Delayed-onset Neutropenia Induced by Anti-CD20 Monoclonal Antibodies Frequently Occurs During Maintenance Therapy and Is Preferentially Associated with Obinutuzumab." Annals of Hematology, vol. 103, no. 12, 2024, p. 5861, https://doi.org/10.1007/s00277-024-06130-y.